Johnson & Johnson has announced the recall of about four million packages of cherry- and grape-flavored Children’s Benadryl allergy tablets and about 800,000 bottles of junior-strength Motrin caplets.

The reason for the recall is vague, with the Benadryl website only offering this statement:

In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. has initiated a voluntary recall of all product lots of Children’s BENADRYL® Allergy FASTMELT® Tablets, in cherry and grape flavors, that were distributed in the United States, Belize, Barbados, Canada, Puerto Rico, St. Martin, and St. Thomas and all product lots of Junior Strength MOTRIN® Caplets, 24 count, that were distributed in the United States.

This is a wholesale and retail level recall. No action is required by consumers or healthcare providers and consumers can continue to use the product. The recall was initiated after a review, conducted as part of McNeil’s Comprehensive Action Plan, revealed insufficiencies in the development of the manufacturing process. There is no indication that the recalled products do not meet quality standards, and this recall is not being undertaken on the basis of adverse events.

Bonnie Jacobs, a company spokeswoman said, “Consumers can continue to use the product; they don’t have to take any action,” The action “is not being taken on the basis of adverse events” or safety issues.